Skip to main content
. 2020 Apr;6(2):a005066. doi: 10.1101/mcs.a005066

Figure 5.

Figure 5.

Drug validation for rhabdomyosarcoma cell lines. BYL-719, GSK1059615, CUDC-907, TC-KHNS11, BEZ-235, BKM-120, and entinostat were tested on RMS cell lines RD (blue), SMS-CTR (red), RMS559 (green), and U57810 (purple) at varying concentrations.